BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW

arrow-up
NAV
₹ 9.742 ₹ 0.05 (0.52 %)
as on 11-07-2025
Asset Size (AUM)
332.33 Cr
Launch Date
Dec 27, 2024
Investment Objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
Minimum Investment 500.0
Minimum Top-up 100.0
Investment Returns Since Launch in Dec 27, 2024
arrow-up

-3.34

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.0 %
Expense Ratio
2.37%
Volatility
0.0 %
Fund House
Bajaj Finserv Mutual Fund
Fund Manager
FM 1 - Mr. Nimesh Chandan (Equity Portion) , FM 2 - Mr. Sorbh Gupta (Equity Portion) , FM-3- Mr. Siddharth Chaudhary (Debt Portion)
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 500.0 (plus in multiples of Rs. 100.0)

Entry Load
Not applicable
Exit Load
Entry load – Nil Exit load – For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP) and Systematic Transfer Plan (STP), exit load will be as follows: • if units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. • if units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable. The Scheme will not levy exit load in case the timelines for rebalancing portfolio as stated in SEBI Master Circular for Mutual Funds dated June 27, 2024, is not complied with. The Trustee / AMC reserves the right to change the load structure any time in the future if they so deem fit on a prospective basis. The investor is requested to check the prevailing load structure of the scheme before investing.
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFDGoldNifty
Fund₹ 10000
FD₹ 10600
Gold₹ 10800
Nifty₹ 11096
Performance

Scheme Performance (%)

Data as on - 11-07-2025
Created with Highcharts 4.1.4ReturnsBAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCWNIFTY Healthcare TRIEquity: Sectoral-Pharma and HealthcareYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesBAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCWNIFTY Healthcare TRIEquity: Sectoral-Pharma and Healthcare2016201720182019202020212022202320242025-20020406080
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund70,00073,1743,17417.11
Benchmark---
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW 27-12-2024 0.0 0.0 0.0 0.0 0.0
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 24.88 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 06-02-2024 22.69 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 17.59 34.11 28.86 24.42 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 17.15 29.09 28.32 23.97 11.6
Portfolio Analysis
Portfolio as on 31-05-2025
Sector Allocation
SectorAllocation (%)
Healthcare83.5
Fast Moving Consumer Goods6.82
Financial Services1.79
Capital Goods1.56
Consumer Services1.34
Chemicals0.49
Portfolio Holdings
CompanyHoldings (%)
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-8.71
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-7.82
CIPLA LIMITED EQ NEW FV RS.2/-6.61
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-5.86
Net Receivables / (Payables)4.5
Dr. Reddys Laboratories Ltd3.52
PIRAMAL PHARMA LIMITED EQ3.5
BIOCON LIMITED EQ3.43
EMCURE PHARMACEUTICALS LIMITED EQ3.4
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-2.81
NEULAND LABORATORIES LIMITED EQ2.76
SYNGENE INTERNATIONAL LIMITED EQ2.65
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ2.63
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-2.42
ABBOTT INDIA LIMITED EQ2.33
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-2.24
PFIZER LIMITED EQ2.24
SANOFI CONSUMER HEALTHCARE INDIA LIMITED EQ2.08
RAINBOW CHILDRENS MEDICARE LIMITED EQ2.01
ZYDUS WELLNESS LIMITED EQ1.94
DR. LAL PATHLABS LIMITED EQ NEW FV RS. 10/-1.9
VIJAYA DIAGNOSTIC CENTRE LIMITED EQ NEW FV Re.1/-1.84
FORTIS HEALTHCARE LIMITED. EQ1.72
HINDUSTAN UNILEVER LIMITED EQ F.V. RS 11.58
Shaily Engineering Plastics Limited1.56
ALKEM LABORATORIES LIMITED EQ1.52
ORCHID PHARMA LIMITED EQ NEW FV RS. 10/-1.38
EMAMI LIMITED EQ NEW F.V. RE.1/-1.37
MEDI ASSIST HEALTHCARE SERVICES LIMITED EQ NEW FV Rs.5/-1.35
MEDPLUS HEALTH SERVICES LIMITED EQ NEW FV RS.2/-1.34
JUBILANT PHARMOVA LIMITED EQ NEW FV RE.1/-1.28
ALEMBIC PHARMACEUTICALS LIMITED EQ1.27
MAX HEALTHCARE INSTITUTE LIMITED EQ1.23
LUPIN LIMITED EQ NEW F.V. RS.2/-1.2
MARICO LIMITED NEW EQ RE.11.18
ASTRAZENECA PHARMA INDIA LIMITED EQ NEW FV RS.2/-1.13
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-1.12
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-0.89
Nestle India Ltd0.75
NEOGEN CHEMICALS LIMITED EQ0.49
PB FINTECH LIMITED EQ NEW FV RS. 2/-0.44
Sector Allocation
Created with Highcharts 4.1.4HealthcareFast Moving Consumer GoodsFinancial ServicesCapital GoodsConsumer ServicesOthers
Portfolio Holdings
Created with Highcharts 4.1.4DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-CIPLA LIMITED EQ NEW FV RS.2/-APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-Net Receivables / (Payables)Dr. Reddys Laboratories LtdPIRAMAL PHARMA LIMITED EQBIOCON LIMITED EQEMCURE PHARMACEUTICALS LIMITED EQOthers